348 related articles for article (PubMed ID: 28053515)
1. Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes.
Forsslund H; Yang M; Mikko M; Karimi R; Nyrén S; Engvall B; Grunewald J; Merikallio H; Kaarteenaho R; Wahlström J; Wheelock ÅM; Sköld CM
Int J Chron Obstruct Pulmon Dis; 2017; 12():35-48. PubMed ID: 28053515
[TBL] [Abstract][Full Text] [Related]
2. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects.
Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
Clin Exp Immunol; 2007 Oct; 150(1):22-9. PubMed ID: 17614970
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.
Barczyk A; Pierzchała W; Kon OM; Cosio B; Adcock IM; Barnes PJ
J Allergy Clin Immunol; 2006 Jun; 117(6):1484-92. PubMed ID: 16751017
[TBL] [Abstract][Full Text] [Related]
4. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
5. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
6. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
7. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
8. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
[TBL] [Abstract][Full Text] [Related]
9. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction.
Forsslund H; Mikko M; Karimi R; Grunewald J; Wheelock ÅM; Wahlström J; Sköld CM
Chest; 2014 Apr; 145(4):711-722. PubMed ID: 24264182
[TBL] [Abstract][Full Text] [Related]
10. CD8(+) Tc-lymphocytes immunodeviation in peripheral blood and airway from patients of chronic obstructive pulmonary disease and changes after short-term smoking cessation.
Yu MQ; Liu XS; Wang JM; Xu YJ
Chin Med J (Engl); 2013; 126(19):3608-15. PubMed ID: 24112150
[TBL] [Abstract][Full Text] [Related]
11. Increased intraepithelial (CD103+) CD8+ T cells in the airways of smokers with and without chronic obstructive pulmonary disease.
Mikko M; Forsslund H; Cui L; Grunewald J; Wheelock AM; Wahlström J; Sköld CM
Immunobiology; 2013 Feb; 218(2):225-31. PubMed ID: 22652413
[TBL] [Abstract][Full Text] [Related]
12. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis.
Katchar K; Eklund A; Grunewald J
J Intern Med; 2003 Dec; 254(6):564-71. PubMed ID: 14641797
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between subpopulations of regulatory T cells in COPD.
Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking.
Barceló B; Pons J; Ferrer JM; Sauleda J; Fuster A; Agustí AG
Eur Respir J; 2008 Mar; 31(3):555-62. PubMed ID: 18057064
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of CCL4/MIP-1β in CD8+ cells and CD4+ cells in sarcoidosis.
Barczyk A; Pierzchała E; Caramori G; Sozańska E
Int J Immunopathol Pharmacol; 2014; 27(2):185-93. PubMed ID: 25004830
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.
Saetta M; Mariani M; Panina-Bordignon P; Turato G; Buonsanti C; Baraldo S; Bellettato CM; Papi A; Corbetta L; Zuin R; Sinigaglia F; Fabbri LM
Am J Respir Crit Care Med; 2002 May; 165(10):1404-9. PubMed ID: 12016104
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.
Roos-Engstrand E; Pourazar J; Behndig AF; Blomberg A; Bucht A
Respir Res; 2010 Sep; 11(1):128. PubMed ID: 20863413
[TBL] [Abstract][Full Text] [Related]
18. Airway regulatory T cells are decreased in COPD with a rapid decline in lung function.
Eriksson Ström J; Pourazar J; Linder R; Blomberg A; Lindberg A; Bucht A; Behndig AF
Respir Res; 2020 Dec; 21(1):330. PubMed ID: 33317530
[TBL] [Abstract][Full Text] [Related]
19. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD.
Shirai T; Suda T; Inui N; Chida K
Allergol Int; 2010 Mar; 59(1):75-82. PubMed ID: 20035145
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD.
Knobloch J; Yakin Y; Körber S; Grensemann B; Bendella Z; Boyaci N; Gallert WJ; Yanik SD; Jungck D; Koch A
Eur J Pharmacol; 2016 Oct; 788():294-305. PubMed ID: 27343379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
